aditXt (Nasdaq ADTX)

Aditxt, Inc. is a biotechnology company focused on developing innovative treatments for chronic diseases by improving the health of the immune system. The company operates through three main divisions: Adimune™, Pearsanta™, and Adivir™. Adimune™ develops pre-clinical stage medications for restoring immune tolerance and delivering long-lasting treatment results for chronic diseases. Pearsanta™ provides personalized, data-driven diagnostic and monitoring solutions for optimal health and wellness. Adivir™ develops innovative medicines, diagnostics, and vaccines to address public health threats and improve population health.

Aditxt is headquartered in Mountain View, California, and operates a CLIA accredited 24/7 laboratory in Richmond, Virginia. The company is publicly traded on the Nasdaq Stock Market under the symbol "ADTX". Aditxt has a robust pipeline of products in development, and is committed to bringing game-changing medicines to patients in need.

Aditxt, Inc. is a biotechnology company focused on improving the health of the immune system to prolong life and enhance its quality. They have developed a portfolio of technologies, including Adimune™, Pearsanta™, and Adivir™, which aim to restore immune tolerance, provide personalized data-driven diagnostics and monitoring solutions, and develop innovative medicines, diagnostics, and vaccines to address public health threats. Through their diverse pipeline of pre-clinical and clinical stage candidates, Aditxt is committed to discovering, developing, manufacturing, and delivering game-changing medicines for various diseases to those in need.

Aditxt, Inc. promotes a culture focused on innovation and collaboration. They invite individuals who share their passion for advancing innovations to join their community of scientists, healthcare professionals, and individuals. Their website emphasizes their commitment to improving global health, suggesting a mission-driven and purpose-oriented work environment.